Skip to search formSkip to main contentSkip to account menu

MAGE-10.A2

Known as: MAGE10.A2 
A synthetic nonapeptide derived from a melanoma-associated antigen. Vaccination with MAGE-10.A2 may stimulate a host cytotoxic T-cell response… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Phase I study of a multipeptide melanoma vaccine (MPV) (MAGE-10.A2, Melan-A ELA, NY-ESO-1b, tyrosinase leader) in patients with melanoma (M)
7551 Background: Vaccination of melanoma (M) patients (pts) with a combination of cancer-testis and M associated peptides may… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)